Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium

被引:33
作者
Bozdogan, Ö
Atasoy, P
Erekul, S
Bozdogan, N
Bayram, M
机构
[1] Kirikkale Univ, Fac Med, Kirikkale, Turkey
[2] Ankara Univ, Fac Med, TR-06100 Ankara, Turkey
[3] Kirikkale State Hosp, Minist Hlth, Kirikkale, Turkey
关键词
endometrial cancer; hyperplasia; apoptosis; Bcl-2; Bax; Bcl-x; estrogen receptor; progesterone receptor; androgen receptor;
D O I
10.1097/01.PGP.0000035807.01856.93
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The purpose of this study was to evaluate the distribution and frequency of apoptosis-related proteins and their correlation with estrogen, progesterone, and androgen receptors in endometrial tissues. Immunohistochemical analyses of bcl-2, bax, bcl-x, and steroid receptors were performed in 22 endometrial carcinomas, 26 endometrial hyperplasias, and 19 cases of normal cyclical endometrium. Bcl-2 was expressed in 45.4% of carcinomas and 92.3% of hyperplasias. Bax immunostaining was found in 90.9% of carcinomas and 76.9% of hyperplasias. Bcl-x positivity was similar in carcinomas (68.1%) and endometrial hyperplasias (76.9%). In nor-Mal cyclical endometria, bcl-2 staining was intense and diffuse in the proliferative phase, but decreased dramatically in the early and mid-secretory phase to reappear in the late secretory phase. Bax was expressed throughout the menstrual cycle but more strongly in the secretory phase. Bcl-x displayed a similar degree of expression in proliferative and secretory endometria. Nineteen carcinomas (86.3%), 25 hyperplasias (96.1%), and 18 normal cyclical endometria (94.7%) were positive for estrogen receptor (ER). Progesterone receptor (PR) was observed in 20 carcinomas (90.9%), all hyperplasias (100%), and 18 normal cyclical endometria (94.7%). Androgen receptor (AR) positivity was seen in 7 carcinomas (31.8%), 6 hyperplasias (23.0%), and 3 normal cyclical endometria (15.7%). There was a statistically positive correlation between bcl-x and ER and a tendency toward significant correlation between bcl-x and PR and between ER and PR in carcinomas. In hyperplasias, there was a significant positive correlation between bcl-2 and PR and between bcl-2 and bax and a negative correlation between ER and bax. There was a statistically significant difference for bcl-2 (p = 0.001) and bax (p = 0.001) between the hyperplasia and carcinoma groups. There was increased expression of bax. decreased expression of bcl-2, and persistence of bcl-x protein in advanced endometrial carcinomas. Our findings show that ovarian hormones have a regulatory role on bcl-2 protein and that there is a correlation between other members of the bcl-2 family (bcl-x and bax) and steroid hormone receptors. Bax/bcl-x may be the major control mechanisms of apoptosis in advanced carcinomas; other members of the bcl-2 family may also be under hormonal control.
引用
收藏
页码:375 / 382
页数:8
相关论文
共 36 条
[1]   Down-regulation of Bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia [J].
Amezcua, CA ;
Zheng, WX ;
Muderspach, LI ;
Felix, JC .
GYNECOLOGIC ONCOLOGY, 1999, 73 (01) :126-136
[2]  
[Anonymous], BLAUSTEINS PATHOLOGY
[3]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[4]   Aromatase as a therapeutic target in endometriosis [J].
Bulun, SE ;
Zeitoun, KM ;
Takayama, K ;
Simpson, E ;
Sasano, H .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (01) :22-27
[5]   THE BCL-2 CANDIDATE PROTO-ONCOGENE PRODUCT IS A 24-KILODALTON INTEGRAL-MEMBRANE PROTEIN HIGHLY EXPRESSED IN LYMPHOID-CELL LINES AND LYMPHOMAS CARRYING THE T(14,18) TRANSLOCATION [J].
CHENLEVY, Z ;
NOURSE, J ;
CLEARY, ML .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :701-710
[6]  
Cotran K.C., 1999, ROBBINS PATHOLOGIC B
[7]   Differential expression of antiapoptotic genes in human endometrial carcinoma:: bcl-XL succeeds bcl-2 function in neoplastic cells [J].
Crescenzi, E ;
Criniti, V ;
Pianese, M ;
Tecce, MF ;
Palumbo, G .
GYNECOLOGIC ONCOLOGY, 2000, 77 (03) :419-428
[8]   Lack of bcl-2 persistence: An independent prognostic indicator of poor prognosis in endometrial carcinoma [J].
Geisler, JP ;
Geisler, HE ;
Wiemann, MC ;
Zhou, Z ;
Miller, GA ;
Crabtree, W .
GYNECOLOGIC ONCOLOGY, 1998, 71 (02) :305-307
[9]  
GOMPEL A, 1994, AM J PATHOL, V144, P1195
[10]   Hormonal carcinogenesis [J].
Henderson, BE ;
Feigelson, HS .
CARCINOGENESIS, 2000, 21 (03) :427-433